|
2021-01-26 |
2021-01-26 |
K
Kauf
|
BridgeBio Pharma, Inc.
Großaktionär
|
14.428.836
0,00
0 USD
|
14.428.836
|
0,00
|
0 USD
|
|
|
2021-01-15 |
2021-01-13 |
GV
Geplanter Verkauf
|
Sinha Uma
Chief Scientific Officer
Geschäftsführender Verwaltungsratsmitglied
|
300
-0.1%
126,39
37.917 USD
|
300
-0.1%
|
126,39
|
37.917 USD
|
|
|
2021-01-15 |
2021-01-13 |
GV
Geplanter Verkauf
|
Sinha Uma
Chief Scientific Officer
Geschäftsführender Verwaltungsratsmitglied
|
2.000
-0.6%
125,35
250.700 USD
|
2.000
-0.6%
|
125,35
|
250.700 USD
|
|
|
2021-01-15 |
2021-01-13 |
GV
Geplanter Verkauf
|
Sinha Uma
Chief Scientific Officer
Geschäftsführender Verwaltungsratsmitglied
|
4.934
-1.6%
124,72
615.362 USD
|
4.934
-1.6%
|
124,72
|
615.362 USD
|
|
|
2021-01-15 |
2021-01-13 |
GV
Geplanter Verkauf
|
Sinha Uma
Chief Scientific Officer
Geschäftsführender Verwaltungsratsmitglied
|
1.498
-0.5%
123,48
184.971 USD
|
1.498
-0.5%
|
123,48
|
184.971 USD
|
|
|
2021-01-15 |
2021-01-13 |
GV
Geplanter Verkauf
|
Sinha Uma
Chief Scientific Officer
Geschäftsführender Verwaltungsratsmitglied
|
572
-0.2%
122,27
69.937 USD
|
572
-0.2%
|
122,27
|
69.937 USD
|
|
|
2021-01-15 |
2021-01-13 |
GV
Geplanter Verkauf
|
Sinha Uma
Chief Scientific Officer
Geschäftsführender Verwaltungsratsmitglied
|
696
-0.2%
121,11
84.292 USD
|
696
-0.2%
|
121,11
|
84.292 USD
|
|
|
2021-01-13 |
2021-01-12 |
V
Verkauf
|
Valle Franco
Senior Vice President, Finance
Führungsperson
|
1.747
-100.0%
125,45
219.152 USD
|
1.747
-100.0%
|
125,45
|
219.152 USD
|
|
|
2021-01-13 |
2021-01-11 |
V
Verkauf
|
Valle Franco
Senior Vice President, Finance
Führungsperson
|
1.500
-100.0%
125,61
188.408 USD
|
1.500
-100.0%
|
125,61
|
188.408 USD
|
|
|
2020-12-16 |
2020-12-15 |
V
Verkauf
|
Turtle Cameron
Chief Business Officer
Führungsperson
|
3.493
-6.5%
112,97
394.589 USD
|
3.493
-6.5%
|
112,97
|
394.589 USD
|
|
|
2020-12-16 |
2020-12-15 |
V
Verkauf
|
Turtle Cameron
Chief Business Officer
Führungsperson
|
11.445
-17.5%
112,19
1.284.018 USD
|
11.445
-17.5%
|
112,19
|
1.284.018 USD
|
|
|
2020-12-16 |
2020-12-15 |
V
Verkauf
|
Turtle Cameron
Chief Business Officer
Führungsperson
|
7.600
-10.4%
111,31
845.937 USD
|
7.600
-10.4%
|
111,31
|
845.937 USD
|
|
|
2020-12-16 |
2020-12-15 |
V
Verkauf
|
Turtle Cameron
Chief Business Officer
Führungsperson
|
3.756
-4.9%
110,29
414.251 USD
|
3.756
-4.9%
|
110,29
|
414.251 USD
|
|
|
2020-12-04 |
2020-12-02 |
GV
Geplanter Verkauf
|
Sinha Uma
Chief Scientific Officer
Geschäftsführender Verwaltungsratsmitglied
|
200
-0.1%
92,97
18.593 USD
|
200
-0.1%
|
92,97
|
18.593 USD
|
|
|
2020-12-04 |
2020-12-02 |
GV
Geplanter Verkauf
|
Sinha Uma
Chief Scientific Officer
Geschäftsführender Verwaltungsratsmitglied
|
300
-0.1%
91,89
27.567 USD
|
300
-0.1%
|
91,89
|
27.567 USD
|
|
|
2020-12-04 |
2020-12-02 |
GV
Geplanter Verkauf
|
Sinha Uma
Chief Scientific Officer
Geschäftsführender Verwaltungsratsmitglied
|
702
-0.2%
90,63
63.625 USD
|
702
-0.2%
|
90,63
|
63.625 USD
|
|
|
2020-12-04 |
2020-12-02 |
GV
Geplanter Verkauf
|
Sinha Uma
Chief Scientific Officer
Geschäftsführender Verwaltungsratsmitglied
|
3.798
-1.2%
89,63
340.402 USD
|
3.798
-1.2%
|
89,63
|
340.402 USD
|
|
|
2020-11-13 |
2020-11-11 |
V
Verkauf
|
Turtle Cameron
Chief Business Officer
Führungsperson
|
908
-1.7%
75,23
68.308 USD
|
908
-1.7%
|
75,23
|
68.308 USD
|
|
|
2020-11-13 |
2020-11-11 |
V
Verkauf
|
Turtle Cameron
Chief Business Officer
Führungsperson
|
9.497
-15.2%
74,75
709.860 USD
|
9.497
-15.2%
|
74,75
|
709.860 USD
|
|
|
2020-11-13 |
2020-11-11 |
V
Verkauf
|
Turtle Cameron
Chief Business Officer
Führungsperson
|
3.005
-4.6%
73,56
221.060 USD
|
3.005
-4.6%
|
73,56
|
221.060 USD
|
|
